Director's Dealing • Mar 20, 2020
Director's Dealing
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information
RNS Number : 8888G
UDG Healthcare Public Limited Co.
20 March 2020
Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them
These forms are required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Damien Moynagh
Anna Moynagh
2
Reason for the notification
a)
Position/status
D Moynagh: PDMR - General Counsel & Company Secretary
A Moynagh: Spouse of PDMR
b)
Initial Notification Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
UDG Healthcare plc
b)
LEI
549300IWG5ZPP6B8HH13
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument,
type of
instrument
Identification code
Ordinary Shares of €0.05 each in UDG Healthcare plc
ISIN: IE0033024807
b)
Nature of the transaction
(i) Purchase of shares
c)
Price(s) and volume(s)
| Price | Volume |
| (i) £4.774 per share | 2,000 Ordinary shares |
| (ii) £4.310 per share | 1,000 Ordinary shares |
d)
Aggregated information
- Aggregated volume
- Price
| Average Price | Aggregated Volume |
| £4.542 per share | 3,000 Ordinary shares |
e)
Date of the transaction
2020-03-18
f)
Place of the transaction
London Stock Exchange, Main Market
g)
Additional Information
Shares held jointly by Damien Moynagh and Anna Moynagh.
For further information, please contact:
Dervala Leahy
Group Assistant Company Secretary
Tel: +353873325861
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHFLFVTVFIALII
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.